Drug
Amlessa
Amlessa: highest development phase Post-Market, developed by Krka. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Krka
Trials
| Drug | Phase | Indication |
|---|---|---|
| Amlessa® NCT03738761 | Post-Market | Hypertension |
Latest
No recent events.
Follow Amlessa on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.